Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409900 · ClinicalTrials.gov registry record · NA
Lumbar Plexus Block Versus Quadratus Lumborum Block for Primary Anterior Total Hip Arthroplasty
A NA study of Osteoarthritis and Total Hip Arthroplasty, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT03409900: Completed NA study of Osteoarthritis and Total Hip Arthroplasty, sponsored by Wake Forest University Health Sciences.
NCT03409900 is a NA study of Osteoarthritis and Total Hip Arthroplasty that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 44 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03409900, a NA study of Osteoarthritis and Total Hip Arthroplasty, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Total hip arthroplasty (THA) is one of the most successful orthopedic procedures to effectively relieve pain and restore function in patients with end stage osteoarthritis. In an attempt to accelerate recovery many orthopedic surgeons have opted to utilize a direct anterior approach (DAA) as opposed to the more traditional posterolateral approach (PLA). The literature supports that DAA is superior to PLA with regard to lower blood loss, less pain, shorter hospital stay, and faster rehabilitation. Traditionally the study team has performed Lumbar Plexus blocks (LPB) to provide post-operative analgesia for total hip arthroplasty. The quadratus lumborum block (QLB) is a newer regional analgesic technique that may be as effective as LPB at providing pain control following DAA hip arthroplasty. This study is designed to compare the efficacy, with regards to post-operative pain management, between LPB and QLB following a DAA total hip arthroplasty.
Primary Outcome
Quantified on an 10 point pain scale with 0 representing "no pain" and 10 representing "worst pain imaginable". Higher scores denotes worse outcomes.
Conditions Studied
Interventions
- OTHER LPB
- OTHER QLB
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2019-11-22 |
| Phase | NA |
What the finished NCT03409900 record still lists
NCT03409900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which LPB is the first listed.
NCT03409900 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03409900 about?
NCT03409900 is a clinical study titled "Lumbar Plexus Block Versus Quadratus Lumborum Block for Primary Anterior Total Hip Arthroplasty". Total hip arthroplasty (THA) is one of the most successful orthopedic procedures to effectively relieve pain and restore function in patients with end stage osteoarthritis. In an attempt to accelerate recovery many orthopedic surgeons have opted to utilize a direct anterior approach (DAA) as opposed...
What is the current status of trial NCT03409900?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2019-03-04. Estimated completion is 2019-11-22.
What conditions does trial NCT03409900 study?
This clinical trial studies the following conditions: Osteoarthritis, Total Hip Arthroplasty.
What interventions are being tested in trial NCT03409900?
The interventions under investigation include: LPB (OTHER), QLB (OTHER).
Who is sponsoring clinical trial NCT03409900?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03409900 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03409900's enrollment target sits among peer trials
44 120th of 135 higher than 16 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
RECRUITING · NA
-
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI